TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
VaccinJouren i Karlstad AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,216
|
1,703
|
1,609 |
| Financial expenses |
195
|
17
|
182 |
| Earnings before taxes |
175
|
576
|
461 |
| EBITDA |
296
|
462
|
561 |
| Total assets |
8,954
|
8,769
|
7,790 |
| Current assets |
3,107
|
2,684
|
2,081 |
| Current liabilities |
50
|
99
|
109 |
| Equity capital |
8,904
|
8,670
|
7,672 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
99.4%
|
98.9%
|
98.5% |
| Turnover per employee |
1,216
|
1,703
|
1,609 |
| Profit as a percentage of turnover |
14.4%
|
33.8%
|
28.7% |
| Return on assets (ROA) |
4.1%
|
6.8%
|
8.3% |
| Current ratio |
6214.0%
|
2711.1%
|
1909.2% |
| Return on equity (ROE) |
2.0%
|
6.6%
|
6.0% |
| Change turnover |
-518
|
-20
|
464 |
| Change turnover % |
-30%
|
-1%
|
41% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.